Drugs@FDA document
TECENTRIQ HYBREZA Letter · BLA 761347 SUPPL-2
Drugs@FDA document · GENENTECH INC · Aug 19, 2025
Key facts
| Drug name | TECENTRIQ HYBREZA |
|---|---|
| Document type | Letter |
| Application | BLA761347 |
| Submission | SUPPL-2 |
| Company | GENENTECH INC |
| Document date | Aug 19, 2025 |
| FDA document | accessdata.fda.gov |
At a glance
- Labeling-Package Insert Document categories
- 10–99 Documents for this application
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: